Taclonex - 50222-227-04 - (calcipotriene and betamethasone dipropionate)

Alphabetical Index


Drug Information of Taclonex

Product NDC: 50222-227
Proprietary Name: Taclonex
Non Proprietary Name: calcipotriene and betamethasone dipropionate
Active Ingredient(s): .5; 50    mg/g; ug/g & nbsp;   calcipotriene and betamethasone dipropionate
Administration Route(s): TOPICAL
Dosage Form(s): OINTMENT
Coding System: National Drug Codes(NDC)

Labeler Information of Taclonex

Product NDC: 50222-227
Labeler Name: LEO Pharma Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021852
Marketing Category: NDA
Start Marketing Date: 20080601

Package Information of Taclonex

Package NDC: 50222-227-04
Package Description: 100 CARTON in 1 CASE (50222-227-04) > 1 TUBE in 1 CARTON > 60 g in 1 TUBE

NDC Information of Taclonex

NDC Code 50222-227-04
Proprietary Name Taclonex
Package Description 100 CARTON in 1 CASE (50222-227-04) > 1 TUBE in 1 CARTON > 60 g in 1 TUBE
Product NDC 50222-227
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name calcipotriene and betamethasone dipropionate
Dosage Form Name OINTMENT
Route Name TOPICAL
Start Marketing Date 20080601
Marketing Category Name NDA
Labeler Name LEO Pharma Inc.
Substance Name BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE HYDRATE
Strength Number .5; 50
Strength Unit mg/g; ug/g
Pharmaceutical Classes Vitamin D [Chemical/Ingredient],Vitamin D Analog [EPC],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]

Complete Information of Taclonex


General Information